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I'd like to begin with a few remarks about the National Cancer Program. It seems
to me that this commitment, involving as I hope it will for the comingyear something
around 800 million dollars, presents a unique opportunity for the planning of both
fundamental and applied science, with a very good chance of achieving a proper
balance between the two. This is a safe enough prediction, depending on whether or
not we can agree on how to define the terms.
There are a number of extremely important applied problems, each carrying a
fairly high degree of feasibility, and these are already being organized and launched
with competence. Most of them are concerned with improving or perfecting today's
best technology for the treatment, diagnosis or prevention of cancer. They do not
provide final answers to the problem, but this is not what they are intended to
accomplish; instead, they are aimed at making sure that the best possible use is made
of today's information. As examples, they include first and foremost, excelling all
others, far and away the most effective and steadily improving ofall our measures for
treating cancer to date, surgery. The development, improvement and ultimate perfec-
tion of surgical techniques for the extirpation ofcancer, from various organs counted
unapproachable 25 years ago, has been nothing short of a tour de force, and, for all
its remaining limitations, a considerable scientific achievement. Also on the list of
active areas of applied research are the innovations in radiation therapy, and the
treatment of childhood malignancies, such as osteogenic sarcoma, with combinations
of surgery, chemotherapy and radiation therapy, improvements in chemotherapy and
radiation for leukemia and the lymphomas, and attempts to improve survival in a
variety of cancers by today's empirical, admittedly crude methods for stimulating
immune responsiveness. Large-scale studies are required to obtain adequate data for
questions of this order, and a relatively high degree of organized effort on the part of
teams of investigators is needed; there has to be general agreement all around as to
who is going to do what, and when, and by what methods.
The Cancer Program has received public criticism on grounds that it is a narrowly
targeted program, directed at a single human disease, and therefore it drains support
away from other categorical fields ofdisease research, and, especially, from the whole
broad area of non-categorical, fundamental biomedical science.
I doubt that there is anyone involved in cancer research today who is not worried,
publicly or privately, by these concerns. It is true that cancer research is now
supported on a substantially larger scale than any other field ofdisease research, and
it is also true that there has been a deplorable and growing shortage of funds for the
support of basic biological science in general. However, this is no argument for a
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All rights of reproduction in any form reserved.reduction in funds for the Cancer Program. I am convinced that the funds currently
being made available are badly needed and essential. However, I also believe that the
other institutes of NIH have been dangerously underfunded over the past eight years,
and I would hope in particular that the National Institute for General Medical
Sciences, which is by far the best and most appropriate source for the support of
basic, undifferentiated biomedical science, can be very greatly strengthened.
In the meanwhile, however, it ought to be a lucky thing, for medicine and biology
both, that the problem of cancer is itself the broadest of all problems in biological
science. It ought to be a lucky thing, since it will probably be impossible for cancer to
be explained in any real depth without exploring fields which represent virtually
every field of biology. Moreover, the problem of human cancer brushes against
disease mechanisms which may underlie a wide variety of other, seemingly unrelated
diseases-for example, rheumatoid arthritis, multiple sclerosis, the "slow virus"
diseases, certain genetic disorders of early life, the so-called autoimmune diseases.
Therefore, it is entirely appropriate that funds earmarked for cancer research should
be deployed for high-merit projects in other institutes ofNIH, especially the Institute
for General Medical Sciences, for as long as other funds for such projects are not
available. The planning of science for cancer ought to include careful plans for
sharing and collaboration with the other institutes, not as a measure for bailing out
impoverished programs but as a rational, sensible, entirely self-interested way of
finding out more about cancer itself.
And now, if I may, I would like to move beyond the cancer problem and consider
some much more general aspects of the planning of science, science in general,
biological science in particular, and science for the long-term future.
If there are, as is sometimes claimed, certain matters that human beings are better
off for not knowing about, or things that we ought not be trying to understand, I
cannot imagine what these might be. Therefore I do not propose to get into this line
of argument beyond acknowledging that the argument does exist. I take it as
axiomatic that science is a useful, intelligent and productive sort ofhuman behavior,
and, as our collective social activities go, it has a considerably better record than
most. Moreover, I doubt that it will make a great deal ofdifference, in the very long
run, whether any or even all of us were to decide that science was, for one reason or
another, a bad thing and should be voted away. It is now a permanently established
part of our social structure, and it will not go away. To be sure, it has only become a
dominant part of human behavior during the last 300 years or so, but it represents an
explosively successful expression of the most fundamental ofall human urges, which
is to find out about things. We seem to have agreed, informally, a few centuries ago,
that we were not likely ever to find all the meaning we need by making it up out ofour
own heads, so we set about doing science, and I believe we will keep at it, for a long
time to come.
I believe that science is a good thing for the human mind, and as important for the
development of collective human thought as any of the other forms of art that seek
for meaning. I don't think its influence has yet penetrated the inner layers of our
consciousness to the extent that literature has, orpainting, ormusic, but perhaps this
is because science is still only at its beginning. I cannot imagine any terminal point in
its future, nor any line of inquiry that will prove inaccessible.
I am aware ofthe dangers ofhubris in this line ofthinking. We do runcertain risks,
especially in biological science, and all of us are aware ofthem. The new technology
that permits the stitching together of DNA from different sources, bacterial, viral,
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even human, and the possible hazards to life posed by such man-made micromon-
sters, have sent a chill through the microbiological community, but by and large the
people who work in this field are properly cautious and apprehensive, as are the
people who support the laboratories concerned, and I am confident that these hybrids
will be handled with appropriate respect. Incidentally, hubris is a peculiarlyappropri-
ate and perhaps prophetic word here, since it is etymologically the same word as
hybrid. Hubris and hybrid were constructed in Greek from two Indoeuropean roots
signifying outrage. Hybrid was originally used to describe the fantastically undesir-
able offspring of the wild boar and the domestic sow. Like many ofour oldest words,
it carries its own warning inside.
There are, of course, other kinds of hazards ahead. The press has caught sight of
some of these, and we are entering what I hope will be a temporary phase in which
science is considered too risky for words. Along with oil spills, strip-mining and
herbicidal warfare, for which science gets blamed, we are also suspected of making
plans to clone eminent politicians, or transplant heads, or devise drugs to control
human behavior to our personal liking. People are becoming fearful ofscience, and I
would too if I thought such things were likely to happen. Which I do not.
Set against the possible hazards of new and better science are the self-evident
benefits. There are three general categories of benefit, which I would list in the order
of their importance to humanity as follows: First, a more comprehensive understand-
ing of nature, and a consequent enrichment of the human spirit. Second, more
information which can be used to solve major human problems in the future,
especially problems relating to human disease. Third, a kind of information that can
be put to use directly, the minute it is obtained, forpractical and beneficial purposes.
The first category, that of understanding and meaning, I do not propose to deal
with further in this talk. Although it ranks at the top ofmy list (orperhaps because it
is there) I could not possibly deal with it and have time to discuss the other two. And
it is the other two about which most of us are deeply worried today, and with which
society's decisions about the planning of science are most directly concerned.
I intend to talk about the difference between basic and applied science, for this is
actually the center of today's argument. It is a particularly agitated argument in the
biomedical sciences, and this year-and I expect for some years to come-it is also,
separately, an argument about how science should be carried out in the problem of
cancer.
The great trouble with talking about basic and applied science is that people think
you are arranging scientists into social castes, with differing and antagonistic customs
and manners. The terms have become loaded, with bogus meanings. Basic scientists
are always pictured as sunk in profundities, thinking every inch ofthe way, fishing up
obscure bits ofinformation for which there can be no conceivable use, and ill-paid for
their infinite pains. Applied scientists are well-off, athletic chaps, using otherpeople's
research to manufacture things that can be sold at a profit, superficial, unmeditative.
Clinical scientists, a term which includes anyone working on human disease mechan-
isms these days, are caught somewhere in the middle, often labelled as applied
scientists when they are engaged in perfectly straightforward basic research, and then
rebuked for not emerging promptly with marketable products.
Because of metaphors like these, the terms basic and applied have lost much of
their usefulness, and when they come into general conversation they tend to cause
more trouble than they seem worth. Nevertheless, I would like to use them for this
discussion, on condition that I can make them mean exactly what I want them to
mean. The terms can be very useful if you are going to consider the planning of
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foundations or universities or research institutes. They are, in fact, two entirely
different kinds of scientific effort, and it is perfectly fair to call one basic and the other
applied if you're scrupulously fair-minded about what the terms signify. Unless you
manage to keep them separate in your mind, and plan for them as quite different
kinds of activity, you run the danger of ending up without any good science at all.
Applied science, then, according to my definition, is the kind of scientific activity
that you must engage in when you are almost entirely certain how an experiment, or a
chain of experiments, is going to turn out. The potential usefulness or profitability of
the outcome has nothing to do with the matter; the outcome could simply be
entertaining or philosophically illuminating, and it would still be applied science if
you start out with a very high degree of certainty. To become engaged in this kind of
work, you have to start out with an orderly and abundant array ofindisputable facts,
better still a redundant array, and these facts inform you that the outcome is notjust
a possibility, or even a probability, but nearly a dead certainty.
There are several outstanding examples of this sort of applied science in biology.
The Salk vaccine is a particularly instructive one. The indisputable facts at hand,
many of them provided by basic scientists working with Paul and Horstmann here at
Yale, were that there were three types of polio virus, and no more, that all three were
good antigens, and that they could be provided in infinite quantities by Enders' tissue
culture techniques. Once these things were known it was an absolute certainty that a
vaccine against poliomyelitis could be made for human use. This was not to suggest
that the work would be easy, or undemanding of high immunologic skill, or any less
rigorous and sophisticated than any other set of experiments in biomedical science.
Just that it was a certainty, and the work that was then performed by Salk and his
associates was a masterpeice of elegant applied science. But it had to be organized
and controlled in a quite different way from the preceding basic research.
The development in the past several years of better and constantly more effective
chemotherapy against acute childhood leukemia is another example. It became a
certainty, or a near-certainty, that if the right combinations ofcertain drugs could be
worked out, affecting different points in the cell cycle, and if their administration
could be timed and monitored correctly, the disease could be cured in more children,
and the rate of sustained remissions rose from under 20% to a substantially higher
figure, now well over 50%. The work required meticulous attention and great caution,
involving a large number of skilled investigators, and it turned out as had been
predicted by the most knowledgeable people in the field. Something like this has also
happened in the therapy of Hodgkins disease and certain other lymphomas, and most
spectacularly in a number of the solid cancers of childhood.
In some respects, this kind of applied research resembles the moon-shot, or the
proximity fuse, or the hydrogen bomb, and it is fair enough to draw analogies
between the planning of biomedical and physical science when you are working at
this level. You obviously need a high degree of organization. Management skills are
indispensable in both the planning and the doing of the science. The logic ofsystems
analysis may be invaluable. All of the scientists involved are under an obligation
to work together in team-fashion, and everyone must stick closely to an agreed
schedule.
It is a distinguishing characteristic ofany really great piece ofapplied science that if
it doesn't turn out the way it is supposed to, the people engaged in the work are
surprised and dismayed. Something really quite awful must have gone wrong.
In basic science, everything is precisely the opposite. The shock, and the surprise,
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come when the experiment does turn out as you hoped. The surprise is pleasure.
Instead ofcertainty about the outcome, you have to start out with a very high degree
ofuncertainty. It is all right to pretend confidence, and to go around your laboratory
bragging that this or that experiment is doomed to come out as you predict, but if
you always have the nagging, uncomfortable hunch that it's going to turn out to be
another dud, you're doing basic science, under my classification.
Generally speaking, the uncertainty of basic science is due to the fact that what is
being looked for is really an idea that will fit with another idea, a connection and a
meaning, perhaps a mechanism, and when you aredealingwith work ofthis kind you
have to rely on your imagination. It is a form of gambling, but the great difference
from real gambling is that if you are lucky, and win, your first thought has to be that
maybe you'd better go back and do the experiment all over again, just for luck.
You can measure the quality ofthe work by the intensity ofthe surprise. Any really
significant piece of new information about nature is likely to be flabbergasting.
Sometimes, if you are in a lucky streak, the surprise will simply be your own
astonishment at being right. At other times, it will be a surprise that something else
turned up; instead of coming out the way you hoped, the experiment revealed
something else, totally unexpected, unpredicted and unpredictable.
Well, how do you plan and organize this kind of science? I really have no answer
for this, except that I am absolutely certain that you can't turn it,just by wishing, into
a primarily management problem, with the solutions now dependent upon the proper
kind of organization charts, team deployment, systems analysis and neat labels inside
sequentially arranged boxes with big arrows and little arrows running back and forth
between them.
Now, you do need skilled, hardworking committees to arrange the doing ofapplied
science, and the success of the outcome may very well depend on the quality of
committee planning. On the other hand, committees, even small committees com-
posed of the brainiest people in town, can be the death ofbasic science. Not always,
of course; once in a while it happens that acommittee memberwill cry out inanguish
because a new idea hasjust fought its way up into his consciousness, but the chances
are statistically better, in my opinion, that the idea would have come sooner and with
greater clarity if he'd been away from the committee, stumbling down the corridor, or
staring out of his laboratory window, or maybe shaving.
The really good ideas, the sudden intuitive perceptions of connections between
seemingly unrelated bits of information, the sudden overwhelming revelations that
make a scientist worry seriously about what would happen to the fate ofthe world if
he were hit by a truck on his way to work, occur in individual minds, and theycannot
be programmed or planned.
If I am right about these things, then the most important and difficult step in the
planning of science is to decide where the problem stands on the issue ofcertainty. If
you have lots of good hard facts, all pointing plainly to a predictable outcome, it
makes no difference how difficult the technological steps or how sophisticated the
instruments required; ifyou line up the investigators in the right orderand lay out the
work in a properly systematic fashion, you get what you want, sooner or later. But if
you make a mistake at the outset in your evaluation ofthe certainty ofthe position,
and if what you are really needing are good hunches and flashes ofintuition, it will be
a disaster. If you try to organize basic uncertainty science in this manner you'll get
nothing out of it except more uncertainty in an endless, impenetrable series of
committee reports, all equally depressed and depressing.
I have a strong hunch that most of the important and interesting questions in
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high uncertainty. There is an abundance of new and fascinating information, and
there are a good many enticing theories concerning the key issues of etiology, the
fundamental mechanisms underlying neoplastic transformation, the possible role of
immunologic reactants, the nature of viral transformation, and even new approaches
to chemical control of neoplastic cells. But, despite the richness of the new informa-
tion, and the increasing speed with which it is being accumulated, I do not sense any
general feeling of certainty at this time about anyfundamental aspect of the cancer
problem. It seems to me a completely safe prediction that ifand when the time comes
when there is a general and comprehensive answer to the problem ofcancer, this will
be an event of overwhelming surprise; indeed, I'd go so far as to predict that the first
reaction of most of us in this room will be "But that is impossible!" Needless to say,
the almost immediate second reaction in some quarters may be "Ah yes, that is really
what my group has been saying for some time," but the very first response will be
dumfoundment. And how do we make plans for that?
Meanwhile, there are important parts ofthe problem that lend themselves nicely to
the most exacting methods of applied science right now, and there will be more of
these in the years just ahead, if we are lucky. We need to develop better techniques of
assessment so that these can be recognized quickly, and capitalized on-like the
childhood leukemia story, for example. But there are not many, not yet, and we must
not make the mistake of trying to force them into existence before their time.
A similar situation exists for most of the other major human diseases. There is a
limited number of problems where certainty has already led to major achievements in
applied science; the outstanding example is, I suppose, the development ofthe whole
field of antibiotic therapy for bacterial infections. For the most part, however, we are
in unknown territory, engaged in a running hunt, and we will have to rely on the same
chaotic, disorderly, spontaneous, unmanageable and uncontrollable manifestations
of the human intellect that have brought the natural sciences to their present stature
over the last couple of hundred years.
Come to think of it, even though it isn't yet clear just how it worked, it hasn't
worked out all that badly, you know. We stumbled our way into chemistry and
evolution, quantum mechanics and relativity turned up, genetics evolved with a life
of its own, microbiology blundered its way along from 1875 into the era of antibiot-
ics, and here today, all unplanned for and unpredicted, are molecular biology,
immunology, neurophysiology and, who knows, experimental psychology. I cannot
believe that any committee, no matter how bright, could have sat down 40 years ago,
when I was a medical student, and laid plans in anticipation of today's biological
science.
We owe an enormous debt to the past, but we have an even harder obligation to the
future. We must concede that the future exists, and that there is a tremendous
amount of highly important work to be done which we will never know anything
about, and cannot even guess at today. This requires of us more humility than we are
accustomed to display, and we must dig deep to find it.
So far, the whole enterprise has been a reasonable success. We are entitled to
celebrate the body of science as one of the greatest of all human accomplishments,
and we can do this without any risk of seeming to boast, provided we make it clear
that we are describing the whole science, and all its history. Where we get ourselves
into deep trouble is by seeming to claim that science is something we just invented
around say, two decades ago, and, having invented it, we're about to figure out some
really neat ways of doing it better and quicker. We didn't invent it, and we haven't
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really discovered yet any qualitatively different ways of doing it, and we certainly
can't claim to understand how the system works. The best we can do, ifwe want to
improve it, is to continue reminding ourselves of the principal features of the
scientific structure that we have inherited from our forebears. It is a legacy passed
straight down from the longer, more ancient tradition ofscholarship, and it includes
honesty, the endlessly rewarding and uniquely human gratification that comes with
the opportunity to tell someone else everything you know about something new and
important, the pleasure that comes from surprise, and certain congenial habits of
work: these include meticulousness, self-criticism, skepticism, an obsession with
making notes and references to the work of predecessors; in short, rigor. With these
and the odd surfacing ofgenius, and all without any master-planning in advance, we
obtained, long ago, Faraday, Maxwell, Gibbs, Einstein, Bohr and Heisenberg,
Pasteur, Ehrlich, Metchnikoff, and a tremendous list of today's luminaries too long
to mention, and heaven knows who tomorrow. With so many other things in doubt,
it is comforting to know that the tradition is so old and so powerful, and so
spectacularly lucky, and that, whatever today's weather, it is certainly here to stay.
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